×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Candel Therapeutics Inc. (CADL) NASDAQ

$1.77 0.03 (1.44%)

Market Cap: $50.32M

As of 02/28/24 03:59 PM EST. Market closed.

(CADL)

Candel Therapeutics Inc. (CADL)
NASDAQ

$1.77
0.03 (1.44%)

Market Cap: $50.32M

As of 02/28/24 03:59 PM EST. Market closed.

Add to Portfolio

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's ... read more

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
88
Address
.
PRICE CHART FOR CANDEL THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.75
Previous Close
$1.74
Days Range
$1.71 - $1.80
52 week range
$0.66 - $2.06
Volume
71,331
Avg. Volume (30 days)
149,958
Market Cap
$50.32M
Dividend Yield
-
P/E
(1.58)
Shares Outstanding
28,919,810
Open
$1.75
Previous Close
$1.74
Days Range
$1.71 - $1.80
52 week range
$0.66 - $2.06
Volume
71,331
Avg. Volume (30 days)
149,958
Market Cap
$50.32M
Dividend Yield
-
P/E
(1.58)
Shares Outstanding
28,919,810
FINANCIAL STATEMENTS FOR CANDEL THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CANDEL THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Tyagarajan SeshuChief Technology OfficerNov 28, 2023 Option Exercise$0.9017,32815,595174,230Nov 30, 2023, 05:00 PM
Tak Paul PeterChief Executive OfficerNov 28, 2023 Option Exercise$0.9043,44339,099373,556Nov 30, 2023, 05:00 PM
Nichols William GarrettChief Medical OfficerNov 28, 2023 Option Exercise$0.9012,17510,957135,126Nov 30, 2023, 05:00 PM
Barone FrancescaChief Scientific OfficerNov 28, 2023 Option Exercise$0.9019,74817,773186,657Nov 30, 2023, 05:00 PM
Amello JasonChief Financial OfficerNov 28, 2023 Option Exercise$0.9020,15318,138202,009Nov 30, 2023, 05:00 PM
Martell ChristopherDirectorDec 09, 2022 Buy$1.9223,95045,984152,000Feb 17, 2023, 06:40 PM
Martell ChristopherDirectorDec 08, 2022 Buy$1.683,0505,124128,050Feb 17, 2023, 06:40 PM
Barone FrancescaChief Scientific OfficerDec 08, 2022 Buy$1.611,2381,9932,738Dec 12, 2022, 04:30 PM
PAPA JOSEPH CDirectorDec 09, 2022 Buy$1.9435,01867,93538,032Dec 12, 2022, 04:25 PM
PAPA JOSEPH CDirectorDec 08, 2022 Buy$1.703,0145,1243,014Dec 12, 2022, 04:25 PM
Martell ChristopherDirectorDec 09, 2022 Buy$1.9223,95045,984152,000Dec 12, 2022, 04:25 PM
Martell ChristopherDirectorDec 08, 2022 Buy$1.683,0505,124128,050Dec 12, 2022, 04:25 PM
Tak Paul PeterChief Executive OfficerDec 09, 2022 Buy$1.9212,93524,83540,985Dec 12, 2022, 04:25 PM
Tak Paul PeterChief Executive OfficerDec 08, 2022 Buy$1.703,0505,18528,050Dec 12, 2022, 04:25 PM
Tyagarajan SeshuChief Technology OfficerDec 09, 2022 Buy$1.9310,35819,99113,358Dec 12, 2022, 04:25 PM
Tyagarajan SeshuChief Technology OfficerDec 08, 2022 Buy$1.693,0005,0703,000Dec 12, 2022, 04:25 PM
Amello JasonChief Financial OfficerDec 09, 2022 Buy$1.932,4684,7635,568Dec 12, 2022, 04:25 PM
Amello JasonChief Financial OfficerDec 08, 2022 Buy$1.693,1005,2393,100Dec 12, 2022, 04:25 PM
Aguilar Laura K.10% OwnerMay 06, 2022 Option Exercise$3.6568,534250,1491,033,840May 10, 2022, 06:07 PM
Aguilar Laura K.10% OwnerMay 06, 2022 Option Exercise$1.46171,335250,1491,102,374May 10, 2022, 06:07 PM
Aguilar-Cordova EstuardoDirectorMay 06, 2022 Option Exercise$3.6554,074197,3701,097,032May 10, 2022, 06:04 PM
Aguilar-Cordova EstuardoDirectorMay 06, 2022 Option Exercise$1.46135,183197,3671,151,106May 10, 2022, 06:04 PM
Manning Paul BDirectorJul 29, 2021 Buy$8.001,625,00013,000,0001,681,000Aug 04, 2021, 04:41 PM
Martell ChristopherDirectorJul 29, 2021 Buy$8.00125,0001,000,000125,000Aug 02, 2021, 08:12 PM
Nguyen DiemDirectorJul 29, 2021 Buy$8.0010,00080,00010,000Aug 02, 2021, 08:11 PM
Tak Paul PeterChief Executive OfficerJul 29, 2021 Buy$8.0025,000200,00025,000Aug 02, 2021, 08:09 PM
Canepa John JChief Financial OfficerJul 29, 2021 Buy$8.0010,12581,00010,125Aug 02, 2021, 08:06 PM
Caffo NathanChief Business OfficerJul 29, 2021 Buy$8.006,00048,0006,000Aug 02, 2021, 08:02 PM
Manning Paul BDirectorJul 29, 2021 Buy$7.3020,000145,94456,000Jul 29, 2021, 09:02 PM
Manning Paul BDirectorJul 27, 2021 Buy$7.3636,000264,83436,000Jul 29, 2021, 09:02 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Tyagarajan SeshuChief Technology Officer11/28/202315,595
Tak Paul PeterChief Executive Officer11/28/202339,099
Nichols William GarrettChief Medical Officer11/28/202310,957
Barone FrancescaChief Scientific Officer11/28/202317,773
Amello JasonChief Financial Officer11/28/202318,138
Martell ChristopherDirector12/09/202245,984
Martell ChristopherDirector12/08/20225,124
Barone FrancescaChief Scientific Officer12/08/20221,993
PAPA JOSEPH CDirector12/09/202267,935
PAPA JOSEPH CDirector12/08/20225,124
Martell ChristopherDirector12/09/202245,984
Martell ChristopherDirector12/08/20225,124
Tak Paul PeterChief Executive Officer12/09/202224,835
Tak Paul PeterChief Executive Officer12/08/20225,185
Tyagarajan SeshuChief Technology Officer12/09/202219,991
Tyagarajan SeshuChief Technology Officer12/08/20225,070
Amello JasonChief Financial Officer12/09/20224,763
Amello JasonChief Financial Officer12/08/20225,239
Aguilar Laura K.10% Owner05/06/2022250,149
Aguilar Laura K.10% Owner05/06/2022250,149
Aguilar-Cordova EstuardoDirector05/06/2022197,370
Aguilar-Cordova EstuardoDirector05/06/2022197,367
Manning Paul BDirector07/29/202113,000,000
Martell ChristopherDirector07/29/20211,000,000
Nguyen DiemDirector07/29/202180,000
Tak Paul PeterChief Executive Officer07/29/2021200,000
Canepa John JChief Financial Officer07/29/202181,000
Caffo NathanChief Business Officer07/29/202148,000
Manning Paul BDirector07/29/2021145,944
Manning Paul BDirector07/27/2021264,834
Load More Insider Transactions
FUNDS WITH A POSITION IN CANDEL THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC139,2530.00002%No changeOther
BLACKROCK INC.49,2850%-1.13%Other
RENAISSANCE TECHNOLOGIES LLC18,6750.00004%NewOther
CHANGE IN SHARES OUTSTANDING FOR CANDEL THERAPEUTICS INC
STOCK BUYBACKS FOR CANDEL THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0%
1Q
09/30/2023
03/31/2023
0%
2Q
09/30/2023
12/31/2022
0.07%
3Q
09/30/2023
09/30/2022
0.10%
4Q
09/30/2023
06/30/2022
0.38%
5Q
09/30/2023
03/31/2022
0.80%
6Q
09/30/2023
12/31/2021
53.23%
7Q
09/30/2023
09/30/2021
23.98%
8Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0%
1Q
03/31/2023
0%
2Q
12/31/2022
0.07%
3Q
09/30/2022
0.10%
4Q
06/30/2022
0.38%
5Q
03/31/2022
0.80%
6Q
12/31/2021
53.23%
7Q
09/30/2021
23.98%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CANDEL THERAPEUTICS INC
LOADING...